17 alpha-hydroxyprogesterone caproate has been researched along with Carcinoma, Squamous Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botnar', ER; Chernyĭ, AP; Shendereva, TS; Shvedova, LA; Volostnykh, LV | 1 |
| Cao, B; Zhang, X | 1 |
1 trial(s) available for 17 alpha-hydroxyprogesterone caproate and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Exploration for drug therapy in endometrial carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinoma, Squamous Cell; Double-Blind Method; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Middle Aged; Tamoxifen | 1996 |
1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
[Combined morphologic evaluation of the efficacy of progestin therapy of primary endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Hydroxyprogesterones; Neoplasm Recurrence, Local; Time Factors; Uterine Neoplasms | 1984 |